is semaglutide patented New Delhi, March 19, 2026 – On Friday, the key patent on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking a pivotal shift in the country's India's weight-loss drugs to get
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
India's weight loss drugs to get cheaper as semaglutide patent expires The Economic Times Semaglutide's patent expires today. What does it mean for patients, pharma players and Novo Nordisk? Apotex Leads Race for Generic Ozempic with Tentative FDA Approval Xtalks Novo Nordisk patent expiry opens door to cheaper weight loss drugs in India Reuters
Store: larengifo.com · Domain: larengifo.com


























